Innovation unit : Research

"Research-wise, we are at the top of our game. Boehringer Ingelheim is always looking for innovative routes, and at Biberach they hire talent that can help with this, rather than people they can ‘control’."

Marzieh Funk , Post Doc , CNS Disease Research

first4patients. We deliver breakthrough therapies for patients in unmet need from ideationt of targets to delivery of drug candidates. In our sound and fluid network in Biberach and around the globe, we focus on patients with unmet needs in cardiometabolic diseases, central nervous system diseases, cancer immunology, immunology, respiratory diseases and beyond. We act on emerging science, captured in innovation, collaboration and growth to improve lives.